Synovial macrophage-osteoclast differentiation in inflammatory arthritis

被引:83
作者
Danks, L
Sabokbar, A
Gundle, R
Athanasou, NA
机构
[1] Nuffield Orthopaed Ctr, Dept Pathol, Oxford OX3 7LD, England
[2] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Surg, Oxford, England
关键词
D O I
10.1136/ard.61.10.916
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pathological bone resorption (marginal erosions and juxta-articular osteoporosis) by osteoclasts commonly occurs in rheumatoid arthritis (RA). Objectives: To define the nature of the mononuclear precursor cells from which osteoclasts are formed in inflamed synovial tissues and to determine the cellular and humoral factors which influence osteoclast differentiation. Method: Macrophage (CD14+), non-macrophage (CD14-), and unsorted (CD14+/CD14-) synovial cell populations from RA and inflammatory/non-inflammatory osteoarthritis (OA) synovium were cultured in the presence of receptor activator for nuclear factor kappaB ligand (RANKL) and monocyte-colony stimulating factor (M-CSF; in the presence/absence of prostaglandin E-2 (PGE(2)), interleukin 1beta (IL1beta), tumour necrosis factor alpha (TNFalpha), and IL6). Osteoclast differentiation was assessed by expression of tartrate resistant acid phosphatase (TRAP), vitronectin receptor (VNR), and lacunar resorption. Results: TRAP+ and VNR+ multinucleated cells capable of lacunar resorption were only formed in cultures of CD14+-containing synovial cell populations (that is, CD14+ and CD14+/CD14- cells). No difference in the extent of osteoclast formation was noted in cultures of CD14+ cells isolated from RA, inflammatory OA, and non-inflammatory OA synovium. However, more TRAP+/VNR+ cells and more lacunar resorption was noted in CD14+/CD14- cells from RA and inflammatory OA synovial tissues. The addition of PGE(2), IL1beta, TNFalpha, and IL6 did not increase RANKL/M-CSF-induced osteoclast formation and lacunar resorption of both CD14+/CD14- and CD14+ synovial cell populations. Conclusions: Osteoclast precursors in synovial tissues are CD14+ monocyte/macrophages. The increase in osteoclast formation in cultures of CD14+/CD14- compared with CD14+ synovial cells in RA and inflammatory OA points to a role for CD14- cells in promoting osteoclast differentiation and bone resorption in inflamed synovial tissues by a mechanism which does not involve a direct effect of proinflammatory cytokines/prostaglandins on RANKL-induced macrophage-osteoclast differentiation.
引用
收藏
页码:916 / 921
页数:6
相关论文
共 55 条
[31]  
KUDO O, IN PRESS J PATHOL
[32]   Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation [J].
Lacey, DL ;
Timms, E ;
Tan, HL ;
Kelley, MJ ;
Dunstan, CR ;
Burgess, T ;
Elliott, R ;
Colombero, A ;
Elliott, G ;
Scully, S ;
Hsu, H ;
Sullivan, J ;
Hawkins, N ;
Davy, E ;
Capparelli, C ;
Eli, A ;
Qian, YX ;
Kaufman, S ;
Sarosi, I ;
Shalhoub, V ;
Senaldi, G ;
Guo, J ;
Delaney, J ;
Boyle, WJ .
CELL, 1998, 93 (02) :165-176
[33]   TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand [J].
Lam, J ;
Takeshita, S ;
Barker, JE ;
Kanagawa, O ;
Ross, FP ;
Teitelbaum, SL .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (12) :1481-1488
[34]   ARTHROSCOPIC AND IMMUNOHISTOLOGIC CHARACTERIZATION OF KNEE-JOINT SYNOVITIS IN OSTEOARTHRITIS [J].
LINDBLAD, S ;
HEDFORS, E .
ARTHRITIS AND RHEUMATISM, 1987, 30 (10) :1081-1088
[36]   Proliferation of a subpopulation of human peripheral blood monocytes in the presence of colony stimulating factors may contribute to the inflammatory process in diseases such as rheumatoid arthritis [J].
Moss, ST ;
Hamilton, JA .
IMMUNOBIOLOGY, 2000, 202 (01) :18-25
[37]   RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis [J].
Nakagawa, N ;
Kinosaki, M ;
Yamaguchi, K ;
Shima, N ;
Yasuda, H ;
Yano, K ;
Morinaga, T ;
Higashio, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 253 (02) :395-400
[38]   Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-κB ligand:: Modulation of the expression by osteotropic factors and cytokines [J].
Nakashima, T ;
Kobayashi, Y ;
Yamasaki, S ;
Kawakami, A ;
Eguchi, K ;
Sasaki, H ;
Sakai, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (03) :768-775
[39]   Anti-interleukin 6 receptor antibody treatment in rheumatic disease [J].
Nishimoto, N ;
Kishimoto, T ;
Yoshizaki, K .
ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 :21-27
[40]   Fibroblastic stromal cells express receptor activator of NF-κB ligand and support osteoclast differentiation [J].
Quinn, JMW ;
Horwood, NJ ;
Elliott, J ;
Gillespie, MT ;
Martin, TJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (08) :1459-1466